| For: | Zhang L, Yu WJ, Zhu H, Li HF, Qiao J. Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report. World J Clin Cases 2022; 10(21): 7495-7501 [PMID: 36158023 DOI: 10.12998/wjcc.v10.i21.7495] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i21/7495.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Susanne U. Miedlich, J. Steven Lamberti. Connecting the dots: Understanding and addressing the metabolic impact of antipsychotic and antidepressant medications. Annals of the New York Academy of Sciences 2025; 1546(1): 35 doi: 10.1111/nyas.15301
|
| 3 |
Domenic DiSanti, April Goley, Avni Garg, Bonnie Alexander, Tracie Rivet, Leonardo Marucci, Natascha Lautenschlaeger, Clare Kneis, Chris Parker, Lawrence B. Marks, Morgan S. Jones. Implementation of a Multihospital Electronic Medical Record–Based Insulin Order Set to Reduce Hypoglycemic Events. AACE Endocrinology and Diabetes 2025; doi: 10.1016/j.aed.2025.09.005
|
| 4 |
Karan Varshney, Shivani Panda, Hilary Fernando, Sergiu Sava, Taimur Khan. Impacts of Glucagon-like Peptide-1 Receptor-Agonist (GLP-1 RA) Treatment for Metabolic Disturbances and Weight Gain in Patients on Clozapine/Olanzapine: A Systematic Review. Obesities 2025; 5(4): 72 doi: 10.3390/obesities5040072
|
| 5 |
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, Maxime Taquet, Amanda I. Adler, Ivan Koychev, Rachel Upthegrove, Marco Solmi, Robert McCutcheon, Toby Pillinger, Philip J. Cowen, Catherine J. Harmer. An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders. Nature Mental Health 2025; 3(3): 354 doi: 10.1038/s44220-025-00390-x
|
| 6 |
Jinfang Song, Na Li, Yongru Zhuang, Ya Chen, Chu Zhang, Jian Zhu. Predictive factors of response to liraglutide in patients with type 2 diabetes mellitus and metabolic syndrome. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1449558
|
